ELITE™ AT 6111: Enhanced Polyethylene Resin
ELITE™ AT 6111: Enhanced Polyethylene Resin
ELITE™ AT 6111: Enhanced Polyethylene Resin
ELITE™ AT 6111
Enhanced Polyethylene Resin
Overview ELITE™ AT 6111 Enhanced Polyethylene Resin is an ethylene-octene copolymer based on ELITE™ AT technology
from Dow. This resin is designed for cast stretch machine wrap films in pallet wrap application and offers an optimized
balance of extensibility, impact strength, and puncture resistance.
Main Characteristics:
• Excellent extensibility
• High impact and exceptional puncture resistance
• Excellent processibility with low back pressure and power consumption.
Complies with:
• U.S. FDA FCN 424
• EU, No 10/2011
• Canadian HPFB No Objection
Consult the regulations for complete details.
Notes
These are typical properties only and are not to be construed as specifications. Users should confirm results by their own tests.
1
Base density is estimated using the assumption that every 1000 ppm of antiblock in the finished product raises the density of the
polymer by 0.0006 g/cm³. Base density is the estimated density of the polymer if it did not contain any antiblock.
2
Method B
3
Determined by Highlight Industries, Inc.
Customer Dow strongly encourages its customers to review both their manufacturing processes and their
applications of Dow products from the standpoint of human health and environmental quality to ensure
Notice that Dow products are not used in ways for which they are not intended or tested. Dow personnel are
available to answer your questions and to provide reasonable technical support. Dow product literature,
including safety data sheets, should be consulted prior to use of Dow products. Current safety data sheets
are available from Dow.
Medical NOTICE REGARDING MEDICAL APPLICATION RESTRICTIONS: Dow will not knowingly sell or sample
any product or service (“Product”) into any commercial or developmental application that is intended for:
Applications Policy a. long-term or permanent contact with internal bodily fluids or tissues. “Long-term” is contact which
exceeds 72 continuous hours;
b. use in cardiac prosthetic devices regardless of the length of time involved (“cardiac prosthetic devices”
include, but are not limited to, pacemaker leads and devices, artificial hearts, heart valves, intra-aortic
balloons and control systems, and ventricular bypass-assisted devices);
c. use as a critical component in medical devices that support or sustain human life; or
d. use specifically by pregnant women or in applications designed specifically to promote or interfere with
human reproduction.
Dow requests that customers considering use of Dow products in medical applications notify Dow so that
appropriate assessments may be conducted. Dow does not endorse or claim suitability of its products for
specific medical applications. It is the responsibility of the medical device or pharmaceutical manufacturer
to determine that the Dow product is safe, lawful, and technically suitable for the intended use. DOW
MAKES NO WARRANTIES, EXPRESS OR IMPLIED, CONCERNING THE SUITABILITY OF ANY DOW
PRODUCT FOR USE IN MEDICAL APPLICATIONS.
Disclaimer NOTICE: No freedom from infringement of any patent owned by Dow or others is to be inferred. Because
use conditions and applicable laws may differ from one location to another and may change with time, the
Customer is responsible for determining whether products and the information in this document are
appropriate for the Customer’s use and for ensuring that the Customer’s workplace and disposal practices
are in compliance with applicable laws and other governmental enactments. Dow assumes no obligation
or liability for the information in this document. NO WARRANTIES ARE GIVEN; ALL IMPLIED
WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE ARE
EXPRESSLY EXCLUDED.
NOTICE: If products are described as “experimental” or “developmental”: (1) product specifications may
not be fully determined; (2) analysis of hazards and caution in handling and use are required; (3) there is
greater potential for Dow to change specifications and/or discontinue production; and (4) although Dow
may from time to time provide samples of such products, Dow is not obligated to supply or otherwise
commercialize such products for any use or application whatsoever.
www.dowplastics.com This document is intended for use within Asia Pacific, Europe, Latin America, North America
Published: 2010-06-02